qCancer® Risk CCR. Predisposition for colorectal cancer

qCancer Colorectal is a NGS analysis that simultaneously analyzes 17 main genes associated with colon cancer risk. Colon cancer is the malignant tumor with the highest incidence in Spain, with about 30,000 new cases per year. It affects 1 in 20 men and 1 in 30 women before the age of 74. Most of these cases are sporadic but 30% are hereditary.


qCancer® Panels

The qCancer panels are qGenomics’ commitment to predictive and personalized medicine. Thanks to the use of NGS technology we are able to diagnose hereditary predispositions to develop tumors much more efficiently than before. Identifying individuals that have a higher risk of developing neoplasms is an approach to the medicine of the future, where cancer diagnoses will be diagnosed in increasingly earlier stages and where we can even avoid its manifestation. The knowledge of the carrier status of a mutation that predisposes for the development of  certain neoplasms translates into benefits at different levels: medical controls adjusted to the risk of each individual, possibility of taking measures that allow us to prevent the onset of cancer and, in the case of affected people, a potential therapeutic benefit.


qGenomics offers the study of groups of genes associated with cancer risk based on the needs of specialists and their patients. These genes are analyzed by NGS techniques in combination with classical approaches of molecular genetics, when necessary.

GeneMedian coverageAssociated Phenotype description and OMIM disease ID
BMPR1AJuvenile polyposis syndrome, infantile form
CDH1Gastric cancer, familial diffuse, with or without cleft lip and/or palate137215
CHEK2{Breast and colorrectal cancer, susceptibility to}
EPCAMColorectal cancer, hereditary nonpolyposis, type 8613244
GREM1Polyposis syndrome, hereditary mixed, 1601228
MLH1Colorectal cancer, hereditary nonpolyposis, type 2609310
MSH2Colorectal cancer, hereditary nonpolyposis, type 1; Lynch syndrome, 2120435
MSH6Colorectal cancer, hereditary nonpolyposis, type 5614350
MUTYHAdenomas, multiple colorectal608456
PMS2Colorectal cancer, hereditary nonpolyposis, type 4614337
POLD1Colorectal cancer, susceptibility to, 10612591
POLEColorectal cancer, susceptibility to, 12615083
SMAD4Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050
STK11Peutz-Jeghers syndrome175200
TP53Li-Fraumeni syndrome151623

Descarga el consentimiento informado AQUÍ

Accede a la plataforma de pedidos Pedido sin plataforma
¿Cómo solicitar un test?
1) Preparar la hoja de solicitud del test

Cumplimentar toda la información disponible, especialmente fecha de nacimiento y sexo. Puede ser desde la plataforma (intranet) de pedidos, o bien mediante el documento en PDF.

2) Imprimir la hoja de solicitud.

Una vez debidamente cumplimentada, imprimir y firmar.

3) Recoger la muestra correspondiente.

Destacar la importancia de identificar correctamente la muestra con el nombre o identificador indicado en la solicitud.

4) Preparar adecuadamente para el envío.

Proteger la muestra biológica y adjuntar la hoja de solicitud y el consentimiento informado.

5) Solicitar la recogida de la muestra al 932 301 270
Requisitos de las muestras biológicas
  • Sangre EDTA: 1 tubo de 3-5mL (niños 1mL mínimo).
  • Alternativamente se puede solicitar kit de recogida de saliva o células bucales.
  • Sangre en papel: un mínimo de 10 spots en tarjeta Guthrie o papel de filtro.
Preparación para el envío
Llámenos al 932 301 270 cuando tenga todo preparado y pasaremos a recoger sus muestras.

Las muestras de sangre en EDTA, ADN purificado, saliva y sangre en papel son estables a temperatura ambiente durante 3 o 4 días. Las muestras pueden mandarse, convenientemente protegidas, por correo ordinario o mensajería.